XML 97 R64.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue Interest Purchase Agreement (Additional Information) (Details) - Purchase Agreement - OrbiMed - USD ($)
12 Months Ended
Sep. 12, 2022
Dec. 31, 2022
Sep. 12, 2024
Mar. 12, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Upfront payment received $ 125,000,000.0      
Potential revenue interest second payment to be received $ 75,000,000.0      
Purchase agreement, second payment date Sep. 12, 2025      
Potential revenue interest third payment to be received $ 50,000,000.0      
Purchase agreement, third payment date Sep. 12, 2025      
Applicable payment percentage of quarterly revenue base for first payment 5.00%      
Applicable payment percentage of quarterly revenue base for first and second payment 8.00%      
Applicable payment percentage of quarterly revenue base for first, second and third payment 10.00%      
Revenue interest payment term 45 days      
Cumulative purchaser payments receivable date Sep. 12, 2028      
Percentage of revenue interest payments 100.00%      
Percentage of cumulative purchaser payments 165.00%      
Cumulative purchaser payments repayment date Sep. 12, 2032      
Increase in return cap percentage of cumulative purchaser payments 175.00%      
Amortization of purchase agreement obligation   $ 0    
Effective interest rate   11.40%    
Debt issuance costs   $ 600,000    
Revenue interest payable   $ 2,760,000    
Forecast | Put/Call Options        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Percentage of cumulative purchaser payments     125.00% 120.00%
Maximum        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential revenue interest payment to be received $ 125,000,000.0